The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 13, 2021
Filed:
Aug. 21, 2018
Applicant:
Immunoqure Ag, Dusseldorf, DE;
Inventors:
Adrian Hayday, Orpington, GB;
Kai Kisand, Tartu, EE;
Kai Krohn, Salmentaka, FI;
Annalisa Macagno, Schlieren, CH;
Shimobi Onuoha, Bishop's Stortford, GB;
Paert Peterson, Tallinn, EE;
Mike Rothe, Krailling, DE;
Martin Woodward, London, GB;
Syeda F. Y. Haque, London, GB;
Assignee:
ImmunoQure AG, Dusseldorf, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/09 (2006.01); C07K 16/24 (2006.01); A61P 37/00 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61P 37/00 (2018.01); G01N 33/6869 (2013.01); A61K 2039/505 (2013.01); A61K 2039/57 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7095 (2013.01);
Abstract
Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.